Disc Medicine, Inc. Common Stock (IRON) Financials
Key financial figures for Disc Medicine, Inc. Common Stock (Q2 2026).
Disc Medicine, Inc. reported revenue of $0.00 for Q2 FY2026. The company posted a net loss of $59.5 million, or -$1.54 per share. Free cash flow for the period was -$44.2 million. The figures above are as filed, and the full income statement, balance sheet and cash flow history for Disc Medicine, Inc. are on the SentiSense financials page.
- Revenue
- $0
- Net Income
- -$60M
- EPS
- $-1.54
- Total Assets
- $735M
- Operating Cash Flow
- -$44M
Recent quarters
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| Q2 FY2026 | $0 | -$60M | -$1.54 | -$44M | |
| Q1 FY2026 | $0 | -$64M | -$1.65 | -$62M | |
| Q4 FY2025 | $0 | -$61M | -$1.64 | -$43M | |
| Q3 FY2025 | $0 | -$62M | -$1.77 | -$48M | |
| Q2 FY2025 | $0 | -$55M | -$1.58 | -$48M |
Recent fiscal years
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| FY2025 | $0 | -$212M | -$6.01 | -$181M | |
| FY2024 | $0 | -$109M | -$3.96 | -$94M | |
| FY2023 | $0 | -$76M | -$3.42 | -$74M |
Frequently asked questions
What was Disc Medicine, Inc.'s revenue last quarter?
Disc Medicine, Inc. reported revenue of $0.00 for Q2 FY2026.
Is Disc Medicine, Inc. profitable?
Not in its most recent reported period. Disc Medicine, Inc. reported a net loss of $59.5 million for Q2 FY2026.
When does Disc Medicine, Inc. report next?
Disc Medicine, Inc. is scheduled to report Q3 2026 results on 2026-11-05. That date is an estimate and has not been confirmed by the company.
Full income statement, balance sheet and cash flow for Disc Medicine, Inc. Common Stock on SentiSense, with up to forty quarters and twenty fiscal years of history.